vimarsana.com

Page 9 - Genscript Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

/PRNewswire/ GenScript Biotech Corporation, the world s leading provider of life-science research tools and services, has ramped up production of complex.

Genscript Biotech Co (OTCMKTS:GNNSF) Sees Significant Decrease in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) was the target of a large decline in short interest in July. As of July 15th, there was short interest totalling 7,405,600 shares, a decline of 5.3% from the June 30th total of 7,816,500 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover […]

Contrasting TFF Pharmaceuticals (NASDAQ:TFFP) & Legend Biotech (NASDAQ:LEGN)

TFF Pharmaceuticals (NASDAQ:TFFP – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings. Volatility and Risk TFF Pharmaceuticals has a beta […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.